Humanistic Outcomes Flashcards

1
Q

What is the ECHO Model?

A
  • Economic (payer-centered)
  • Clinical (provider-centered)
  • Humanistic (patient-centered)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some characteristics of the economic outcomes involved in the ECHO model?

A

They are payer-centered (public-funded system and insurance companies)

Direct, indirect, and intangible benefits and losses are measured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some characteristics of clinical outcomes in the ECHO model?

A

They are provider-centered (these are outcomes that HCPs care about)

Changes in morbidity, mortality, and biological markers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some characteristics of humanistic outcomes in the ECHO model?

A

They are patient-centered (this is the main concern for patients)

Utility of intervention, functional status, willingness-to-pay, and patient satisfaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are QALYs?

A

Quality-Adjusted Life Years (QALYs) are a humanistic outcome measure commonly used in health economic evaluation studies

QALY=UtilityxTime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is utility in the context of pharmacoeconomics?

A

It is the patient’s percieved value for a particular health state, and time in that state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is functional status?

A

It is a composite of the dimensions of health

  • Physical (vision, hearing, speech, ambulation)
  • Mental (cognition, emotional well-being)
  • Social interaction
  • Energy
  • Level of pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the purpose of the SF-36 survey?

A

It attempts to evaluate a patient’s functional status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the purpose of the SF-12 survey?

A

It is a shorter version of the SF-12, and the results from the SF-12 is closely correlated with SF-36 score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the best strategy for determining changes to health-related quality of life in response to an intervention?

A

Recommend both a generic and a disease-specific instrument (do not administer one after the other, as we risk overwhelming patient)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is willingness-to-pay?

A

It is based in economic theory and it assigns a monetary value for an outcome

Can be measured indirectly or directly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can willingness-to-pay be measured indirectly?

A

It can be inferred from observing behaviour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can willingness-to-pay be measured directly?

A

Open: respondents are asked to share dollar amount they are “willing to pay”

Closed: respondents asked if willing to pay a specified price (yes or no)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are Discrete Choice Scenarios?

A

Present research participants with hypothetical scenarios involving different service or drug attributes identified as important

This information about preference for different states can be used to price drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is patient satisfaction?

A

It is an evaluation of the quality of care recived and the overall process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are PROMs?

A

Patient-reported outcome measures (PROMs)

They are used to assess a patient’s health status (measure impact of an intervention)

17
Q

What are some types of Patient-reported outcome measures (PROMs)?

A
  • Health-related quality of life
  • Functional Status
  • Symptoms and Symptom Burden
  • Patient Experience of Care
18
Q

What are PREMs?

A

Patient-Reported Experience Measures

A survey that evaluates the patient experience with pharmacy practice

19
Q
A